CONMED CORP (CNMD)
US2074101013 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 24.30M | 28.90M | 20.80M | 27.40M | 25.90M | |||
| Receivables | 242.28M | 191.30M | 183.90M | 177.20M | 189.10M | |||
| Inventories | 318.32M | 332.30M | 231.60M | 194.90M | 164.60M | |||
| Other Current Assets | 30.75M | 28.60M | 23.80M | 17.30M | 17.80M | |||
| Total Current Assets | 615.65M | 581.20M | 460.10M | 416.70M | 397.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 137.33M | 133.30M | 128.30M | 133.10M | 142.00M | |||
| Goodwill | 806.84M | 815.40M | 617.50M | 618.40M | 618.00M | |||
| Intangibles | 649.48M | 681.80M | 471.00M | 501.50M | 532.80M | |||
| Other Non-Current Assets | 90.72M | 85.80M | 89.00M | 82.00M | 84.90M | |||
| Total Non-Current Assets | 1.68B | 1.72B | 1.31B | 1.33B | 1.38B | |||
| TOTAL ASSETS | 2.30B | 2.30B | 1.77B | 1.75B | 1.78B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 708.00K | 69.70M | 12.20M | 18.40M | 13.60M | |||
| Accrued Expenses | 77.58M | 61.70M | 67.70M | 57.60M | 61.00M | |||
| Accounts Payable | 88.22M | 73.40M | 58.20M | 53.30M | 56.00M | |||
| Other Current Liabilities | 144.22M | 91.80M | 58.60M | 60.80M | 57.60M | |||
| Total Current Liabilities | 310.73M | 296.60M | 196.60M | 190.20M | 188.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 973.14M | 985.10M | 672.40M | 735.20M | 755.20M | |||
| Deferred Taxes/Income | 60.90M | 66.70M | 68.50M | 57.90M | 74.50M | |||
| Other Non-Current Liabilities | 121.03M | 203.70M | 43.00M | 59.30M | 46.80M | |||
| Total Non-Current Liabilities | 1.16B | 1.26B | 784.00M | 852.40M | 876.50M | |||
| TOTAL LIABILITIES | 1.47B | 1.55B | 980.60M | 1.04B | 1.06B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 452.53M | 412.60M | 496.60M | 457.40M | 470.80M | |||
| Additional Paid In Capital | 446.54M | 413.20M | 396.80M | 382.60M | 379.30M | |||
| Common Shares | 313.00K | 300.00K | 300.00K | 300.00K | 300.00K | |||
| Treasury Stock | -14.99M | -22.80M | -54.10M | -67.60M | -80.70M | |||
| Other Shareholders' Equity | -50.17M | -57.90M | -54.20M | -63.70M | -59.30M | |||
| Shares Outstanding | 30.77M | 30.50M | 29.40M | 28.90M | 28.40M | |||
| Tangible Book Value per Share | -20.22 | -24.65 | -10.31 | -14.22 | -15.50 | |||
| Total Shareholders' Equity | 834.22M | 745.50M | 785.40M | 709.00M | 710.50M | |||
| TOTAL LIABILITIES AND EQUITY | 2.30B | 2.30B | 1.77B | 1.75B | 1.78B | |||
| Statistics | ||||||||
| Debt/Equity | 1.17 | 1.32 | 0.86 | 1.04 | 1.06 | |||
| Current Ratio | 1.98 | 1.96 | 2.34 | 2.19 | 2.11 | |||
| Return On Assets (ROA) | 2.80% | -3.51% | 3.54% | 0.54% | 1.61% | |||
| Return On Equity (ROE) | 7.73% | -10.81% | 7.96% | 1.34% | 4.03% | |||
| Return On Invested Capital (ROIC) | 4.87% | 2.79% | 5.59% | 3.14% | 4.87% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 4.93% | 2.83% | 5.67% | 3.20% | 4.95% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 19.03% | 11.77% | 19.08% | 11.84% | 18.83% | |||
All data in USD